The stock market is getting Ozempic’ed
The collective shedding of billions of pounds thanks to GLP-1 drugs is poised reshuffle trillions of dollars in the stock market and economy.
Related Articles
Advanced-Stage Classical Hodgkin Lymphoma
Classical Hodgkin lymphoma (HL) is a highly curable disease, but up to 25% of patients will develop relapsed or refractory classical HL. Although most patients…
Discovery of WRN inhibitor HRO761 with synthetic lethality in MSI cancers
Nature – HRO761 is a potent, selective, allosteric WRN inhibitor that binds at the interface of the D1 and D2 helicase domains, locking WRN in…
Potential Protective Effects of Aspirin Against Colorectal Cancer
Researchers may have uncovered how the long-term daily use of aspirin may help prevent the development and progression of colorectal cancer, according to a recent…
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial
Nature Medicine – Treatment of patients with advanced hepatocellular carcinoma with a personalized DNA vaccine in combination with anti-PD-1 therapy was safe and led to…
Medicare Advantage fight shifts to 340B arena
CMS should compel Medicare Advantage plans to retroactively adjust 340B payment rates, hospitals say.
Primary Large B-cell Lymphomas of Immune-Privileged Sites
Diffuse large B-cell lymphoma (DLBCL) encompasses a diverse spectrum of aggressive B-cell lymphomas with remarkable genetic heterogeneity and myriad clinic
ESDO: esdo GI bullets
The addition of Pembrolizumab to perioperative chemotherapy increases the pCR rate, but does not improve the event-free survival (EFS) in locally advanced gastric or gastro-oesophageal…
CCR8 expectations
Blockade of CCR8 has quietly emerged as a hot oncology target, especially for anti-PD-(L)1 MAb combinations.
Alectinib in Resected ALK-Positive Non–Small-Cell Lung Cancer | NEJM
Platinum-based chemotherapy is the recommended adjuvant treatment for patients with resectable, ALK-positive non–small-cell lung cancer (NSCLC). Data on the efficacy and safety of adjuvant alectini…
HCA reports almost $1 billion more in charity care to Medicare than to its shareholders, drawing more taxpayer money
HCA Healthcare, the country’s biggest hospital chain, reported almost $1 billion more in charity care to CMS than in its financial statement, drawing more taxpayer…